What are Radioligand drugs?

Radioligand drugs are pharmacologic agents that share a common mechanism (typically targeting Choline kinase). 0 are currently marketed, with 4 more in clinical development.

Radioligand

0 marketed 2 in Phase 2 2 in Phase 1

This page covers all Radioligand drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Choline kinase, Norepinephrine transporter, PSMA.

Targets

Choline kinase · Norepinephrine transporter · PSMA · folate receptor beta

Phase 2 pipeline (2)

18F-fluoromethylcholine · Queen's Medical Center · Oncology
PET imaging agent for prostate cancer
I-123 mIBG · GE Healthcare · Oncology
I-123 mIBG binds to norepinephrine transporters

Phase 1 pipeline (2)

67Cu-SAR-bisPSMA · Clarity Pharmaceuticals Ltd · Oncology
PSMA-targeting radioligand
99mTc-Etarfolatide · Endocyte · Oncology
binds to folate receptor beta